united states food and drug administration Archives

Intranasal Third-Generation CGRP Effective for Acute Migraine

April 19, 2021 classical migraine, common migraine, dysgeusia, ENT (ears, FDA, headache, headache (migraine), migraine, migraine headache, nausea, nose, otolaryngology, pain, pain (pain management), pain management, receptors, throat, tolerance, U.S. Food and Drug Administration, united states food and drug administration

Intranasal zavegepant, a third-generation calcitonin gene-related peptide (CGRP) receptor agonist, is effective and well tolerated in the treatment of acute

Health News

OCS Heart System Earns Hard-Won Backing of FDA Panel

April 8, 2021 ACS:, acute coronary syndrome, acute coronary syndrome (acs), atherosclerotic cardiovascular disease, atherosclerotic heart disease, back, cardiac imaging, cardiovascular imaging, coronary atherosclerosis, coronary h, CV imaging, dorsal, echo, echocardiogram, echocardiography, FDA, heart, lipid management, lipids, patient safety, U.S. Food and Drug Administration, united states food and drug administration

After more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support

Health News

OCS Heart System Earns Hard-Won Backing of FDA Panel

After more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support

Health News

Moderna Variant-Specific Vaccine Ready to Study

February 24, 2021 2019 Novel Coronavirus, 2019-nCoV, clinical research, clinical studies, clinical trials, Coronavirus, Coronavirus Vaccine, COVID-19 vaccine, FDA, HCoV-229E, HCoV-OC43, health care quality/access/eva, Human coronavirus 229E, Human coronavirus HKU1, Human coronavirus OC43, Immunizations, U.S. Food and Drug Administration, united states food and drug administration, vaccination, vaccine, wuhan coronavirus

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Moderna completed manufacturing a version of